NOVOGEN LIMITED (ASX:NRT)
Company
Key Dates
Announcements
Marshall Edwards Presentation at Novogen 2010 AGM - Dr Dan Gold, President and CEO of Marshall Edwards, Inc.
Thu, 28 Oct 2010 4:00pm
Thu, 28 Oct 2010 3:00pm
Fri, 27 Mar 2009 11:30am
Interview with Professor Gil Mor 
Executives & Directors
Chairman
Non Exec. Director
Non Exec. Director
Non Exec. Director
Non Exec. Director
CFO
Secretary
Please contact the ASX to change these details
Company Podcasts
EGM
Mon, 7 May 2012
Date Payable
Fri, 20 Apr 2012
Record Date
Wed, 18 Apr 2012
Annual General Meeting
Mon, 31 Oct 2011
EGM
Fri, 6 May 2011
Interim Results
Mon, 28 Feb 2011
Annual General Meeting
Wed, 3 Nov 2010
Annual General Meeting
Fri, 30 Oct 2009 3:30pm
Full Year Results
Thu, 27 Aug 2009
Interim Results
Fri, 27 Feb 2009
| Marshall Edwards completes rights offering | Tue, 15 May 2012 |
| Novogen Board approves investment in MEI rights issue | Tue, 8 May 2012 |
| Novogen announces the results if its EGM | Mon, 7 May 2012 |
| Appendix 3B | Mon, 30 Apr 2012 |
| Marshall Edwards issued new patent for ME-143 | Thu, 26 Apr 2012 |
| Appendix 3B | Mon, 16 Apr 2012 |
| Marshall Edwards receives FDA approval for IND for ME-344 | Wed, 11 Apr 2012 |
| Dividend related documents and Prospectus | Tue, 10 Apr 2012 |
| Correction | Thu, 5 Apr 2012 |
| Shareholder documentation for EGM | Thu, 5 Apr 2012 |
Please note: This company appears on this website as a result of its listing on the Australian Securities Exchange. BRR Media does not claim any association with any company listed on this site.
